Osteosarcoma is the most common primary malignant bone tumors, affecting mostly children, adolescents and young adults. This is an aggressive tumor that results in a high mortality rate and poor prognosis. Due to the low sensitivity of osteosarcoma to ionizing radiation, such treatment is not used very often and it can be recommended only to postsurgical therapy. As an alternative therapy, functionalized nanomaterials allow their accumulation in tumor tissues due to their unique properties, making them good agents to act as stable carriers for radionuclides. In this work, mesoporous hydroxyapatite nanoparticles were synthesized and the functionalization process with poly(vinyl alcohol) and collagen was investigated. The samples were characterized by X-ray diffraction (XRD), N 2 adsorption, elemental analysis (CHN), Fourier Transform Infrared Spectroscopy (FTIR), Nitrogen Adsorption, Transmission Electron Microscopy (TEM), and Thermal Analysis. Also, the yttrium incorporation potential and its release kinetics in the hydroxyapatite matrix were evaluated to study the capacity of this system to treat osteosarcomas. The results indicate that this material has a promisor potential to treat this kind of tumor.
Introduction
Osteosarcoma is the most common primary malignant bone tumors, affecting mostly children, adolescents and young adults [1] . The number of new cases of bone tumors up to 19 years is approximately estimated in 670 cases per million inhabitants per year in Brazil [2, 3] . This is an aggressive tumor that results in a high mortality rate and poor prognosis [4] . A neoadjuvant chemotherapy followed by an invasive surgical resection is the most common treatment for this pathology. Due to the low sensitivity of osteosarcoma to ionizing radiation, such treatment is not used very often and it can be recommended only to postsurgical therapy [5] [6] [7] . Considering these difficulties, there is an emergent need to find new therapeutic alternatives.
Nanostructured systems have been widely exploited in biomedical research with great optimism for the diagnosis and therapy of cancer. Nanomaterials, such as mesoporous silica, hydroxyapatite nanoparticles, carbon nanotubes and liposomes, have unique properties that allow their accumulation in tumor tissues, making them good agents to act as carriers for controlled drug release or stable carriers for radionuclides [8] .
Hydroxyapatite (HA) nanoparticles, chemically defined as Ca 10 (PO 4 ) 6 (OH) 2 , have been extensively explored for biological applications due to excellent biocompatibility, bioactivity and similarity to the chemical composition of human bone tissue [9] . The small crystallite size of these nanomaterials is a very important factor related to biological and structural properties, such as surface activity and low dissolution rate [10] . Also, the mesoporous structure of biomaterials allows the easy incorporation of agents, such as radioisotopes, aiming the treatment of pathologies such as osteosarcoma [11] . In addition, the literature show that functionalized HA nanoparticles present great binding rates on osteosarcoma lineages cells [12] .
Bone tissue is an inorganic-bioorganic composite material consisting mainly of collagen (Col) and HA. It is related in the literature that the functionalization process of hydroxyapatite surfaces with collagen improves the adherence of this material on bone like tissues [12] . However, the synthesized biocomposites of collagen and hydroxyapatite alone do not have adequate mechanical properties for some biomedical applications. This behavior can be optimized by polymeric binders that provide improved durability and mechanical properties for these materials [13] . Poly(vinyl alcohol) (PVA) hydrogels exhibit biocompatibility and high elastic modulus, allowing the use of this polymer for several biomedical applications including drug delivery systems and radioisotope carries [14, 15] .
Yttrium-90 is a beta emitter radioisotope (E max = 2.28 MeV) with a half-life of 64 h. This radionuclide has been widely studied as a potential agent for radiation synovectomy [16, 17] , and also showed a good stability for 90 Y-HA preparation for in vitro applications [17] . In addition, this radioisotope has been used in brachytherapy to treat metastatic liver tumors in microspheres labeled systems [18, 19] .
Although hydroxyapatite microparticles containing yttrium-90 had already been studied in some previous works [17, 18] , to the best of our knowledge, no works actually address the investigation of the use of functionalized nanostructured hydroxyapatite in nanometer scale as an yttrium-90 carrier system. The size range of the particles is a very important feature for cancer treatment materials. In inflammatory and hypoxia conditions, typically observed in tumor regions, the endothelial lining of the blood vessel wall becomes more permeable than in the normal state. As a result, large molecules and small particles ranging from 10 to 500 nm can leave the vascular system and accumulate within the interstitial tumor space [8] . The spontaneous accumulation, which works especially well with tumors due to the lack of lymphatic drainage, is known as enhanced permeability and retention (EPR) [8] . Within the pharmaceutical field, the synthetic polymers of vinyl series might protect particulate drug carriers from undesirable interactions with biological surrounded components [20] , making them avoidable to the macrophages and becoming long-circulating materials, allowing them to accumulate in tumor tissues by EPR effect [8, 20] .
The combination of nanostructured materials carriers and radioisotopes presents a promising potential for the treatment of osteosarcoma allowing more selective use of radiation in tumor cells. This approach can increase the sensitivity of tumors to the radiation due to the possibility to maintain the nanostructured carrier between radioisotopes and tumor cells. In this sense the objective of this work is to synthesize a hybrid system of PVA/Col/HA mesoporous nanoparticles conjugated with yttrium and evaluates this system as a potential therapeutic agent for osteosarcoma.
Methods

Hydroxyapatite Production
Mesoporous hydroxyapatite nanoparticles were synthesized using the cationic surfactant method following the literature [21, 22] with some modifications. The HA synthesis started with the preparation of two precursors solutions. Solution (1) was prepared by dissolving a preweighed amount of calcium nitrate, Ca(NO 3 ) 2 •4H 2 O, in Milli-Q ® water to obtain a 0.167 M of calcium concentration. Solution (2) was prepared by dissolving 2 g of cetyltrimethylammonium bromide (CTAB) in Milli-Q ® water and adding a preweighed amount of dipotassium hydrogen phosphate, K 2 HPO 4 •3H 2 O, to obtain a 0.1 M of phosphate concentration. Solution (2) was stirred for 6 hours to promote a net assembly by micelles formation and its pH was adjusted to 12 with NaOH 2.5 M during the slowly drop-wise addiction of Solution (1) . After the dropping process, the final solution was aged at room temperature during 14 hours. The resultant solution was conducted to a hydrothermal treatment at 100˚C during 10 hours. After, the solution was filtered, dried during 24 hours at 60˚C temperature and calcined during 6 hours at 550˚C to obtain a fine white powder.
HA/PVA/Col Functionalization
The functionalization of HA nanoparticles with PVA and collagen process was performed following the literature [13, 14] with some modifications. A solution of 7.3 wt% PVA was prepared by dissolving pre-weighed amounts of PVA in Milli-Q ® water at 90˚C during 6 hours with vigorous stirring. Then, 450 mg of HA was added to 30 mL of PVA solution and kept stirring at 60˚C during 4 hours. After, 600 mg of collagen was added to 20 mL of the HA/PVA solution and stirred at room temperature during 5 hours. The final solution was centrifuged and dried at 40˚C to preserve the collagen structure.
Yttrium Incorporation and Release Assays
Firstly, an aqueous solution of 1:1 (Y:HA/PVA/Col) was 
Yttrium Activation Potential
The yttrium activation potential by (n, γ) nuclear reaction of 89 YCl 3 (131.9 mg) was calculated following the literature [23, 24] for neutron activation on TRIGA IPR-R1 nuclear reactor sited on CDTN/CNEN, Belo Horizonte, Brazil. Equation (1) was feed with TRIGA reactor constants:
where A is the activity, N is the number of target nuclei, ϕ Th is the thermal neutron flux on central tube, σ Th is the radionuclide thermal neutron cross section, ϕ EPI is the epithermal neutron flux on central tube, I γ is the radionuclide capture resonance integral, λ is the radionuclide decay constant (λ = ln2/T 1/2 ; T 1/2 is the radioisotope halflife) and T IR is the irradiation time.
Characterizations
The crystalline phases of synthesized HA nanoparticles were evaluated by X-ray diffraction (XRD, Rigaku Inc., Japan) with CuKα radiation in which data were collected from 4˚ to 80˚ (2θ) with a step size of 4˚/min. Particles size analyses, morphology and porosity of mesoporous HA nanoparticles were evaluated by transmission electron microscopy (TEM, Tecnai G2-12 SpiritBiotwin-FEI Company, Japan). The surface parameters were evaluated by N 2 adsorption (Autosorb iQ-Quantachrome, EUA), the samples were outgassed for 2 hours at 300˚C and the specific surface area was calculated by the traditional method of Brunauer, Emmett and Teller (BET). Fourier transform infrared spectra (FTIR, ThermoScientific-Nicolet 6700, USA) were recorded in the range of 4000 -400 cm -1 with 64 scans to evaluate the chemical composition of the samples. Thermogravimetric analyses (TGA, DTG-60H-Shimadzu, Japan) were carried out under nitrogen atmosphere from room temperature to 800 ˚C. CHN elemental analyses (CHN, 2400-PerkinElmer, USA) were performed to investigate the presence of PVA and collagen on functionalized samples.
Results and Discussion
X-Ray Diffraction
The powder XRD of the synthesized hydroxyapatite is shown on Figure 1 which reveals a single phase formation of hexagonal HA with P63/m space group (JCPDS files: 09-0432) and no characteristic peaks of impurities are observed. This analysis points to a pure production of hydroxyapatite and indicates that the presence of CTAB cannot induce the crystallization of any other phases.
Transmission Electron Microscopy
In order to evaluate the mesoporous HA nanoparticles size, morphology and porosity, transmission electron microscopy was carried out as shown in Figure 2 . The rod like morphology and porosity can be observed in accordance with results from literature [10, 11] . As estimated by the Quantikov Image Analyzer data [25] , the particles are monodisperse and present an average mean diameter of approximately 87 nm. 
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Nitrogen Adsorption Analysis
Nitrogen adsorption isotherm is shown on Figure 3 and the surface parameters of HA nanoparticles determined by BET method are shown on Table 1 . The HA porosity, previously determined by TEM analysis, was confirmed by BET results, indicating that mesoporous particles were produced with 17.5 nm of pore diameter and 0.086 cm 3 /g of pore volume, allowing this material to be used as a radioisotope carrier. The specific surface area found as 56 m 2 /g determines a great potential for functionalization processes.
Fourier Transform Infrared Spectroscopy
The FTIR studies were performed to investigate the chemical composition of the samples. Figure 4(c) shows FTIR spectrum of the HA nanoparticles in agreement with the literature [10, 11, 13] . All the stretching and bending vibrations of the 3 4 PO − and OH − functional groups of hydroxyapatite could be observed. The weak shoulder at 960 cm -1 and strong broad band around 1035 cm -1 corresponds to v 1 and v 3 phosphate stretching modes while the shoulder at 473 cm -1 and the strong peaks at 568 and 604 cm -1 points the presence of v 2 and v 4 phosphate bending modes [11] . The OH − bands could be observed at 3576 and 634 [10] . The broad band observed from 3237 to 3663 cm -1 could be attributed to H 2 O vibration modes. The success of functionalization process was evaluated by comparing FTIR spectra of pure PVA, pure collagen, pure HA and HA/PVA/Col hybrid system as shown on Figures 4-6 . The collagen spectrum (Figure 4(b) ) shows absorption bands of amine I (C=O) at 1660 cm -1 and amine II and III groups at 1449, 1388 and 1239 cm -1 . The 1529 cm -1 peak is associated with the C-N stretching of amines I and II [13] . Figure 4(a) shows the presence of absorption peaks at 869, 663 and 420 cm -1 for PVA. Comparing the scale-expanded FTIR spectrum of pure col and PVA with PVA/Col/HA material (Figures 5 and  6) , it can be observed that some characteristic stretching and bending vibrations present in the PVA and col spectra are observed in the PVA/Col/HA FTIR spectrum in lower intensities. However, we did not observe all characteristic vibrations of the functionalizing groups, because some vibration modes of pure PVA and pure collagen occurred in the same frequency interval of the HA modes (Figure 4). 
Thermogravimetric Analyses
Thermogravimetric analyses were performed to investigate the chemical changes during heat treatment of the synthesized mesoporous hydroxyapatite nanoparticles and to investigate the success of the functionalization process with PVA and collagen. Figure 7 shows the TGA and DTG plots for pure HA, PVA/HA and PVA/Col/HA hybrid systems. There is no significant weight losses for pure HA nanoparticles, suggesting that a thermal stable material was synthesized with great agreement with literature [11] . The weight loss observed up to 250˚C may be attributed to the thermodesorption of physically adsorbed water. Comparing the TGA and DTG plots for PVA/HA and PVA/Col/HA systems, it is possible to visualize weight losses corresponding to PVA and collagen degradations in temperatures ranging around 200˚C to 450˚C. Also, it is possible to infer that these losses are due to the presence of both PVA and collagen in the HA nanoparticle matrix, in agreement with the FTIR analyses, en- forcing that a successful functionalization process was reached.
CHN Elemental Analyses
The presence of PVA and collagen on the functionalized mesoporous HA nanoparticles was also evaluated by CHN elemental analysis which is shown on Table 2 . The functionalized samples presented higher carbon concentrations in both PVA and PVA/Col samples, as compared to the HA nanoparticle matrix, confirming the presence of anchored functionalized agents on its surfaces. The CHN results for PVA/HA sample shows smaller amounts of carbon, hydrogen and nitrogen when compared to PVA/Col/HA sample, indicating that HA nanoparticles was functionalized with both PVA and collagen materials. Table 3 shows the ICP-AES results of yttrium content and release assays. A capacity of adsorption around 32% of yttrium element in PVA/Col/HA matrix can be evaluated from these results, aiming to a concentration of 24 wt% of this element in HA nanoparticles. ICP-AES results also show that no significant yttrium amount can be released from PVA/Col/HA matrix. Table 4 summaries the Equation (1) variable values for TRIGA reactor [23, 24] and shows the theoretical calcu- Table 3 . Yttrium incorporation and release assays. PVA/Col/HA have adequate characteristic to be used in in vitro cell culture studies to determine the cytotoxicity of this sample in UMR-6 cell line. These experiments will be conducted and reported in the due course.
Yttrium Incorporation and Release Assays
Theoretical Evaluation of Yttrium Activation
Conclusion
The characterization results confirm the success of the nanoparticles synthesis in accordance with the expected. The data indicate that the functionalized nanostructures were prepared with adequate characteristic for in vivo applications, showing great yttrium incorporation potential as well as very low release kinetics. These are promisor results for a radioisotope carrier material, considering that a great radioactivity with no radionuclide losses can be associated with this matrix. In view of all results obtained, the system can be considered as a potential therapeutic alternative for the treatment of osteosarcoma.
